MODEX
LIVE

Serial Number

97788161

Owner

ModeX Therapeutics, Inc.

Attorney

Jill Anderfuren

Filing Date

Feb 9, 2023

Add to watchlist:

No watchlists yet
View on USPTO

MODEX Trademark

Serial Number: 97788161

MODEX is a trademark filed by ModeX Therapeutics, Inc. on February 9, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

ModeX Therapeutics, Inc. (4 trademarks)

20 Riverside Rd.
Weston, MA 02493

Entity Type: 03

Trademark Details

Filing Date

February 9, 2023

Registration Date

Not Registered

Published for Opposition

October 28, 2025

Goods & Services

Medical research; Research and development of pharmaceuticals; research and development services in the field of antibodies, and immunotherapies for the treatment of cancer and infectious diseases; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; pharmaceutical research and development; vaccine research and development services; research and development in the field of immunotherapy

Pharmaceuticals for the prevention and treatment of cancer and infectious diseases; therapeutic pharmaceuticals for the prevention and treatment of cancer and infectious diseases; immunopharmaceuticals for the prevention and treatment of cancer and infectious diseases; vaccines; therapeutic vaccines; multispecific antibodies for medical therapeutic purposes; multi-specific immunotherapeutic pharmaceutical compositions for the prevention and treatment of cancer and infectious diseases

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 21, 2026 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Mar 9, 2026 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Nov 25, 2025 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 28, 2025 NPUB
PUBLISHED FOR OPPOSITION
Oct 28, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 22, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 25, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 17, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 17, 2025 CRFA
ASSIGNED TO LIE
Sep 17, 2025 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sep 11, 2025 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Sep 11, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
Sep 11, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
Sep 11, 2025 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Sep 7, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 6, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 6, 2025 GNSL
SUSPENSION LETTER WRITTEN
Mar 6, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 4, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 4, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 4, 2025 TROA
NOTICE OF REVIVAL - E-MAILED
Mar 4, 2025 NREV
PETITION TO REVIVE-GRANTED
Mar 4, 2025 PETG
TEAS PETITION TO REVIVE RECEIVED
Mar 4, 2025 PROA
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Dec 3, 2024 GNS2
INQUIRY TO SUSPENSION E-MAILED
Dec 3, 2024 GNSI
SUSPENSION INQUIRY WRITTEN
Dec 3, 2024 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 19, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 19, 2024 GNSL
SUSPENSION LETTER WRITTEN
Jan 19, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 17, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 16, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 16, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 8, 2023 GNRN
NON-FINAL ACTION E-MAILED
Nov 8, 2023 GNRT
NON-FINAL ACTION WRITTEN
Nov 8, 2023 CNRT
ASSIGNED TO EXAMINER
Nov 7, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 28, 2023 NWOS
NEW APPLICATION ENTERED
Feb 13, 2023 NWAP